Sparks Family Hospital INC
Sparks Family Hospital INC was paid $1.68M by Medicaid between Apr 2022 and Dec 2024, across 103 billing codes. Its largest line is 99285, emergency room visit (most serious) — 26% of everything it billed.
RENO, NV 89511
Next to other General Acute Care Hospital providers in Nevada
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 19,996 | $294K | |
| 2023 | 40,307 | $697K | |
| 2024incomplete | 36,747 | $693K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 26% | 4,598 | 3,882 | $435K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 3,618 | 3,203 | $298K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 13% | 1,007 | 863 | $213K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 3,475 | 3,121 | $180K |
| G0378 | Hospital observation service, per hour | 4.3% | 662 | 482 | $72K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.6% | 3,106 | 2,554 | $61K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.9% | 712 | 623 | $50K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.8% | 1,459 | 1,186 | $31K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.6% | 831 | 769 | $28K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.5% | 1,996 | 1,607 | $26K |
| 80053 | Comprehensive metabolic panel | 1.3% | 5,659 | 4,589 | $23K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.3% | 103 | 88 | $21K |
91 more codes
| 59025 | Fetal non-stress test | 1.2% | 575 | $20K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 7,409 | $19K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,243 | $13K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,666 | $13K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,286 | $12K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,377 | $12K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,503 | $12K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 77 | $10K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,713 | $10K |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,160 | $9K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 141 | $9K |
| 84484 | <1% | 2,363 | $7K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 357 | $7K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 310 | $7K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 59 | $7K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,496 | $6K |
| 83690 | <1% | 2,172 | $6K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 268 | $5K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 89 | $5K |
| 84703 | <1% | 1,416 | $4K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 153 | $4K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 180 | $3K |
| 96376 | <1% | 389 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,174 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 200 | $3K |
| 81001 | <1% | 2,416 | $3K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 954 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,964 | $2K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 41 | $2K |
| 83605 | <1% | 553 | $2K | |
| 76801 | <1% | 33 | $2K | |
| 84702 | <1% | 314 | $2K | |
| 81025 | <1% | 877 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 280 | $2K |
| 83735 | <1% | 650 | $1K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 40 | $1K |
| 87040 | <1% | 341 | $1K | |
| 87561 | <1% | 62 | $1K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,111 | $1K |
| 81003 | <1% | 1,331 | $1K | |
| 85027 | <1% | 595 | $1K | |
| 85610 | <1% | 945 | $842.87 | |
| 87077 | <1% | 349 | $813.19 | |
| 80076 | <1% | 278 | $787.55 | |
| 87186 | <1% | 265 | $732.18 | |
| 84030 | <1% | 307 | $639.80 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 14 | $634.42 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 64 | $511.35 |
| 36416 | <1% | 307 | $511.05 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,549 | $510.05 |
| 85379 | <1% | 121 | $491.42 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,156 | $486.69 |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 13 | $435.21 |
| 85730 | <1% | 320 | $417.71 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 120 | $411.52 |
| 82962 | <1% | 859 | $401.06 | |
| 86901 | <1% | 443 | $388.49 | |
| 86900 | <1% | 446 | $386.39 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,353 | $335.53 |
| 83880 | <1% | 37 | $326.31 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 600 | $313.24 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 668 | $279.49 |
| 84439 | <1% | 75 | $253.53 | |
| 73610 | <1% | 14 | $243.00 | |
| 73564 | <1% | 13 | $238.89 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 496 | $233.84 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 97 | $226.96 |
| 86850 | <1% | 243 | $224.63 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,488 | $192.11 |
| 87070 | <1% | 64 | $189.07 | |
| 73630 | <1% | 14 | $151.51 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 297 | $127.43 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 85 | $108.77 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 103 | $98.03 |
| 94760 | <1% | 162 | $90.48 | |
| 84100 | <1% | 43 | $84.48 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 761 | $73.46 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 129 | $73.09 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 14 | $58.53 |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 16 | $58.38 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 103 | $48.89 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 25 | $25.74 |
| 82570 | <1% | 20 | $24.93 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 403 | $20.91 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 380 | $10.65 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 31 | $8.50 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 23 | $4.30 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 80 | $0.86 |
| A9270 | Non-covered item or service | 0% | 1,042 | $0.00 |
| C1769 | Guide wire | 0% | 20 | $0.00 |
| 0353U | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| District Hospital Partners L P | Washington, DC | $136.25M |
| Mcallen Hospitals L P | Edinburg, TX | $124.61M |
| Lancaster Hospital Corporation | Palmdale, CA | $108.63M |
| Universal Health Services of Rancho Springs INC | Murrieta, CA | $61.95M |
| Doctors Hospital of Laredo | Laredo, TX | $52.31M |
| Valley Hospital Medical Center | Las Vegas, NV | $47.03M |
| Northwest Texas Healthcare System INC | Amarillo, TX | $44.81M |
| Uhs of Bowling Green LLC | Bowling Green, KY | $41.21M |
| Uhs-Corona INC | Corona, CA | $35.18M |
| Spring Valley Medical Center | Las Vegas, NV | $33.58M |
| Aiken Regional Medical Centers LLC | Aiken, SC | $31.51M |
| Summerlin Hospital Medical Center L L C | Las Vegas, NV | $30.26M |
| Manatee Memorial Hospital L P | Bradenton, FL | $22.33M |
| Desert Springs Hospital | Las Vegas, NV | $22.29M |
| Fort Duncan Medical Center LP | Eagle Pass, TX | $15.80M |
| Psi Pride Institute INC | Eden Prairie, MN | $15.57M |
| Uhs of Fuller INC | S Attleboro, MA | $13.47M |
| Uhs of Texoma, INC | Denison, TX | $12.51M |
| Arbour INC | Boston, MA | $12.36M |
| Wellington Regional Medical Center LLC | Wellington, FL | $10.75M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.